MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Mutant WDR45 leads to altered ferroptosis in β-propeller protein-associated neurodegeneration

    S H. Diaw, C. Ganos, S. Zittel, K. Plötze-Martin, L. Kulikovskaja, A. Westenberger, M. Vos, A. Rakovic, M. Dulovic-Mahlow, K. Lohmann (Lübeck, Germany)

    Objective: To functionally characterize WDR45-mediated BPAN (Beta-propeller protein-associated neurodegeneration). Background: BPAN patients usually present with global developmental delay and autistic features in early childhood and…
  • 2022 International Congress

    Blood biomarkers and their association with non-motor symptoms in early Parkinson’s Disease

    J. Kaur, S. Ng, N. Chia, X. Deng, J. Tan, X. Choi, D. Heng, Z. Xu, K. Tay, W. Au, A. Ng, E. Tan, L. Tan (central, Singapore)

    Objective: To identify if baseline blood biomarkers are associated with non-motor symptoms in early PD. Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder with…
  • 2022 International Congress

    The mitochondrial risk score and lifestyle factors are associated with age at onset in LRRK2 p.Gly2019Ser Parkinson’s disease.

    T. Lüth, C. Gabbert, P. Lajer, I. König, A. Caliebe, S. Koch, B-H. Laabs, F. Hentati, S. Sassi, R. Amouri, C. Klein, A. Grünewald, M. Farrer, J. Trinh (Lübeck, Germany)

    Objective: To investigate the relationship between a mitochondrial risk score (MRS), lifestyle and age at onset (AAO) in LRRK2 G2019S Parkinson’s disease (PD). Background: PD…
  • 2022 International Congress

    Magnetic Resonance Image-guided high-intensity focused ultrasound (MRIgFUS) subthalamotomy in Spanish Parkinson’s disease (PD) patients.

    M. Campins-Romeu, R. Baviera-Muñoz, C. Morata-Martinez, I. Sastre-Bataller, R. Conde-Sardon, A. Gutierrez-Martin, I. Martinez-Torres (Valencia, Spain)

    Objective: To describe our preliminary results of MRIgFUS subthalamotomy in two PD patients. Background: MRIgFUS thalamotomy has become the preferred surgical approach for refractory essential tremor…
  • 2022 International Congress

    Visual system abnormalities and visual hallucinations in Parkinson’s disease

    M. Diez-Cirarda, A. Cabrera, A. Murueta-Goyena, A. Strafella, R. Del Pino, MA. Acera, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: We aimed to identify clinical and imaging biomarkers of visual system injury associated with the presence of Visual hallucinations (VH) in Parkinson's disease (PD).…
  • 2022 International Congress

    A low-cost system using a big-data deep-learning framework for assessing physical tele-rehabilitation: a proof-of-concept

    A. Olivares-Gil, JM. Ramírez-Sanz, JL. Garrido-Labrador, á. García-Bustillo, á. Arnaiz-González, JF. Díez-Pastor, J. González-Santos, JJ. González-Bernal, M. Allende-Río, F. Valiñas-Sieiro, JM. Trejo-Gabriel-Galan, E. Cubo (Burgos, Spain)

    Objective: The consolidation of tele-rehabilitation for the treatment of many diseases over the last decades is a result of its cost-effective results and its ability…
  • 2022 International Congress

    Isolated ZIC4 antibody associated paraneoplastic cerebellar degeneration

    A. Agarwal, A. Garg, A. Srivastava (New Delhi, India)

    Objective: Anti-ZIC4 antibodies have recently been associated with paraneoplastic cerebellar degeneration (PCD) and are usually associated with small cell carcinoma lung. However, most of the…
  • 2022 International Congress

    Effectiveness of a home-based exercise program on gait characteristics in an individual with Parkinson’s disease over a one-year period: A case study

    F. Khobkhun, P. Srivanitchapoom, J. Richards (Nakhon Pathom, Thailand)

    Objective: The purpose of this study was to explore the case history of an individual with Parkinson’s disease (PD) who used a home-based exercise programme…
  • 2022 International Congress

    CCL5 promotes Th17 migrating into SNpc by promoting Th17 proportion increase and LFA-1 expression

    XZ. Xue (WuHan, China)

    Objective: To explore the specific pathway by which CCL5 induces Th17 cells migrating into substantia nigra pars compacta (SNpc) to aggravate Parkinson's disease (PD). Background:…
  • 2022 International Congress

    DUtch PARkinson Cohort (DUPARC): Contrast Sensitivity and Retinal Changes in Early Parkinson’s Disease Patients

    C. Gillen, S. Zee, N. Jansonius, T. van Laar (Groningen, Netherlands)

    Objective: To identify and characterize the correlation between static contrast sensitivity (SCS), dynamic contrast sensitivity (DCS), and thickness of the internal plexiform layer (IPL) in…
  • « Previous Page
  • 1
  • …
  • 486
  • 487
  • 488
  • 489
  • 490
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley